logo-loader
viewKromek Group PLC

Kromek Group PLC - Director Share Purchases

RNS Number : 5921W
Kromek Group PLC
12 December 2019
 

12 December 2019

 

Kromek Group plc

("Kromek" the "Company" or the "Group")

 

Director Share Purchases

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security and civil nuclear markets, announces that Sir Peter Williams, Chairman, Dr Arnab Basu, Chief Executive Officer, and Mr Derek Bulmer, Chief Financial Officer, yesterday purchased ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as follows:

 

Name

Title

Number of Ordinary Shares purchased

Price paid per share (pence)

Resulting shareholding

Percentage of issued share capital 

Sir Peter Williams

Chairman

50,000

22.50

200,000

0.06%

Dr Arnab Basu

Chief Executive Officer

20,000

17.95

2,972,000

0.86%

Mr Derek Bulmer

Chief Financial Officer

20,000

17.94

132,292

0.04%

 

 

For further information, please contact:

Kromek Group plc


Arnab Basu, CEO
Derek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)


Max Hartley (NOMAD)
Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)


Harry Chathli
Claire Norbury
Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

 

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

1.   Sir Peter Williams

2.   Dr Arnab Basu

3.   Derek Bulmer

 

2

Reason for the notification

a)

Position/status

1.   Chairman

2.   Chief Executive Officer

3.   Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.   22.50p

2.   17.95p

3.   17.94p

1.   50,000

2.   20,000

3.   20,000

 

d)

Aggregated information

- Aggregated volume
- Price

 

 N/A

e)

Date of the transaction

11 December 2019

f)

Place of the transaction

London Stock Exchange

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHTBBBTMBMBTAL

Quick facts: Kromek Group PLC

Price: 21

Market: AIM
Market Cap: £72.37 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Kromek Group PLC to begin rapid production of ventilators from next week

Kromek PLC's (LON:KMK) Dr Arnab Basu caught up with Proactive London's Andrew Scott after announcing they're turning its manufacturing efforts over to producing medical ventilators. Work will start before the end of the month and he's expecting to have 1,000 units available within eight weeks...

on 15/4/20